See more : NAVA HEALTH MD, LLC (NAVA) Income Statement Analysis – Financial Results
Complete financial analysis of PT Sarana Meditama Metropolitan Tbk (SAME.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Sarana Meditama Metropolitan Tbk, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Kredyt Inkaso S.A. (KRI.WA) Income Statement Analysis – Financial Results
- Empowerment & Inclusion Capital I Corp. (EPWR) Income Statement Analysis – Financial Results
- Entrada Therapeutics, Inc. (TRDA) Income Statement Analysis – Financial Results
- Genertec Universal Medical Group Company Limited (UMTAF) Income Statement Analysis – Financial Results
- Beijing Jingwei Hirain Technologies Co., Inc. (688326.SS) Income Statement Analysis – Financial Results
PT Sarana Meditama Metropolitan Tbk (SAME.JK)
About PT Sarana Meditama Metropolitan Tbk
PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,535.64B | 1,393.54B | 1,271.58B | 507.62B | 529.32B | 952.08B | 775.57B | 635.02B | 515.09B | 414.41B | 336.51B | 270.47B |
Cost of Revenue | 1,101.60B | 916.61B | 729.02B | 275.58B | 316.84B | 527.03B | 418.93B | 339.26B | 261.38B | 210.57B | 172.22B | 149.84B |
Gross Profit | 434.04B | 476.93B | 542.57B | 232.04B | 212.48B | 425.05B | 356.64B | 295.76B | 253.71B | 203.85B | 164.29B | 120.63B |
Gross Profit Ratio | 28.26% | 34.22% | 42.67% | 45.71% | 40.14% | 44.64% | 45.98% | 46.58% | 49.26% | 49.19% | 48.82% | 44.60% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 122.24B | 117.14B | 97.41B | 58.55B | 45.89B | 62.00B | 46.99B | 44.58B | 39.08B | 31.86B | 26.85B | 20.80B |
Selling & Marketing | 21.82B | 15.28B | 7.37B | 12.14B | 11.77B | 17.90B | 13.30B | 11.24B | 9.03B | 8.37B | 5.19B | 3.91B |
SG&A | 393.56B | 132.42B | 104.78B | 70.69B | 57.66B | 79.90B | 60.29B | 55.81B | 48.11B | 40.24B | 32.04B | 24.71B |
Other Expenses | 0.00 | 311.44B | 241.64B | 152.71B | 150.08B | -12.73B | -2.74B | -219.16M | 486.15M | 409.83M | -172.36M | -660.61M |
Operating Expenses | 393.56B | 443.86B | 346.42B | 223.40B | 207.73B | 255.64B | 203.35B | 212.03B | 138.99B | 113.17B | 91.74B | 71.61B |
Cost & Expenses | 1,488.31B | 1,360.47B | 1,075.44B | 498.97B | 524.57B | 782.67B | 622.28B | 551.29B | 400.37B | 323.74B | 263.96B | 221.45B |
Interest Income | 6.03B | 6.80B | 12.72B | 933.99M | 111.47B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 75.98B | 46.21B | 41.09B | 109.73B | 111.47B | 72.76B | 53.31B | 43.24B | 22.50B | 23.44B | 21.42B | 20.39B |
Depreciation & Amortization | 234.19B | 203.24B | 149.78B | 92.98B | 80.22B | 96.45B | 69.87B | 67.03B | 19.33B | 18.37B | 13.63B | 13.62B |
EBITDA | 323.19B | 266.68B | 346.62B | 60.43B | 52.07B | 257.14B | 219.79B | 119.09B | 105.54B | 106.87B | 99.77B | 62.04B |
EBITDA Ratio | 21.05% | 11.46% | 21.93% | 13.59% | 9.77% | 21.51% | 24.49% | 18.75% | 21.70% | 25.88% | 25.54% | 22.92% |
Operating Income | 47.33B | 62.23B | 176.58B | 8.64B | 5.41B | 175.64B | 156.98B | 116.55B | 117.86B | 65.54B | 50.92B | 28.03B |
Operating Income Ratio | 3.08% | 4.47% | 13.89% | 1.70% | 1.02% | 18.45% | 20.24% | 18.35% | 22.88% | 15.81% | 15.13% | 10.36% |
Total Other Income/Expenses | -34.32B | -17.06B | -28.37B | -113.71B | -145.68B | -93.94B | -60.38B | -89.34B | -49.59B | -25.14B | -21.76B | -20.99B |
Income Before Tax | 13.01B | 17.22B | 148.21B | -374.98B | -140.27B | 81.70B | 96.61B | 27.21B | 68.26B | 65.54B | 50.92B | 28.03B |
Income Before Tax Ratio | 0.85% | 1.24% | 11.66% | -73.87% | -26.50% | 8.58% | 12.46% | 4.29% | 13.25% | 15.81% | 15.13% | 10.36% |
Income Tax Expense | -4.73B | 7.64B | 156.46M | 74.48B | -25.89B | 22.82B | 24.59B | 12.42B | 11.66B | 7.47B | 4.27B | 4.76B |
Net Income | 12.25B | 9.58B | 144.17B | -449.47B | -114.39B | 58.88B | 72.01B | 14.80B | 56.61B | 58.07B | 46.65B | 23.27B |
Net Income Ratio | 0.80% | 0.69% | 11.34% | -88.54% | -21.61% | 6.18% | 9.29% | 2.33% | 10.99% | 14.01% | 13.86% | 8.60% |
EPS | 0.71 | 0.56 | 10.64 | -43.85 | -12.62 | 6.50 | 7.94 | 1.63 | 6.24 | 6.36 | 5.17 | 2.57 |
EPS Diluted | 0.71 | 0.56 | 10.64 | -43.85 | -12.62 | 6.50 | 7.94 | 1.63 | 6.24 | 6.36 | 5.17 | 2.57 |
Weighted Avg Shares Out | 17.14B | 17.13B | 13.54B | 10.25B | 9.07B | 9.07B | 9.07B | 9.07B | 9.07B | 9.07B | 9.03B | 9.07B |
Weighted Avg Shares Out (Dil) | 17.14B | 17.13B | 13.54B | 10.25B | 9.07B | 9.07B | 9.07B | 9.07B | 9.07B | 9.07B | 9.03B | 9.07B |
Source: https://incomestatements.info
Category: Stock Reports